(S)-2-(3,5-Dinitrobenzamido)-2-phenylacetic acid, 97%, 500g

3-Chloro-5-iodopyridin-2-amine, 95.0%, 5g

p-Benzoquinonedioxime, 95.0%, 250g

(6-Bromo-3H-imidazo[4,5-b]pyridin-2-yl)methanol, 97.0%, 10g

HPLC-Säule NUCLEODUR®, 100-5 NH2, 5 µm, 125x4,6 mm, 1 Stück

3-[3-(3-Carboxy-acryloylamino)-phenylcarbamoyl]-acrylic acid, 1g

3-(4-Benzyl-1-piperidinyl)propanoic acid, 95+%, 1g

(S)-Methyl 2-(piperidin-3-yl)acetate hydrochloride, 95.0%, 10g

tert-Butyl 7-hydroxy-2-azabicyclo[2.2.1]heptane-2-carboxylate, 97%, 5g

5-(Methoxymethylene)-2,2-dimethyl-1,3-dioxane-4,6-dione, 95.0%, 1g

2-(2-(BENZYLOXY)PHENOXY)-5-PHENYLPENTANOIC ACID, 95.0%, 250mg

2-Chloro-5-nitro-1,3-benzothiazole, 97.0%, 1g

naphthalene-2,6-diamine, 95.0%, 1g